BNH Investment is a venture capital firm that invests in early-stage start-ups in biotechnology and healthcare sectors. We aim to provide experience, knowledge and long-term relationships to give innovative companies the best chance of success. BNH's primary investment areas are pharmaceuticals, diagnostics, medical devices, and cosmeceuticals and we have the proven track record of success; Established in 2015, we had liquidated two funds generating IRRs of 50% and 117%, respectively and currently manage three funds, KRW 72 billion.